Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

NCI awards SPORE grant for lymphoma research

Oct. 7, 2002

New modulators of immunotherapeutic agents described by Altachem and U. of Alberta

Oct. 7, 2002

Igeneon licenses IGN-301 from Novartis

Oct. 4, 2002

Avax signs distribution agreement with Ferrer for AC Vaccine technology

Oct. 4, 2002

Potential use of the HSPPC-96 vaccine in patients with metastatic renal cell carcinoma

Oct. 4, 2002

Allovectin-7 update

Oct. 1, 2002

Monoclonal antibodies targeting human BST2

Oct. 1, 2002

G17DT granted fast track status for pancreatic cancer

Sep. 27, 2002

Update on phase II and III clinical studies of Theratope in breast cancer

Sep. 27, 2002

Nycomed licenses TransMID from KS Biomedix in Europe

Sep. 20, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...